Artificial Intelligence Technology Solutions Inc. announced that Robotic Assistance Devices (RAD), its wholly owned subsidiary, has received a purchase order from a global pharmaceutical company. Adoption of this solution could save the client 75% of the expense of alternative solutions while providing superior performance. The company is finalizing contract details with the potential client and expects to get final contract documents this month.